Characterization of matriptase expression in normal human tissues

Journal of Histochemistry and Cytochemistry

Volumn 51, Issue 8, 2003, Pages 1017-1025

  Oberst, Michael D ^a   Singh, Baljit ^a   Ozdemirli, Metin ^a   Dickson, Robert B ^a   Johnson, Michael D ^a   Lin, Chen Yong ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Hepatocyte growth factor activator inhibitor 1 (HAI 1); Immunohistochemistry; Matriptase; Protease; Transmembrane serine

Indexed keywords

MATRIPTASE; MESSENGER RNA; SCATTER FACTOR; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; COLON; COLUMNAR EPITHELIUM; CONTROLLED STUDY; ENDOCRINE SYSTEM; ENZYME ANALYSIS; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; OVARY CANCER; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SKIN; SQUAMOUS EPITHELIUM; SUBCUTANEOUS TISSUE; TISSUE DISTRIBUTION; TUMOR GROWTH; UROGENITAL SYSTEM;

EID: 0043246607     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540305100805     Document Type: Article

References (16)

1. Andreasen PA, Egelund R, Petersen HH (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57:25-40
2. Comoglio PM, Boccaccio C (2001) Scatter factors and invasive growth. Semin Cancer Biol 11:153-165
3. Kang JY, Dolled-Filhart M, Ocal IT, Singh B, Lin C-Y, Dickson RB, Rimm DL, et al. (2003) Tissue microarray analysis of HGF/met pathway components reveals a role for Met, matriptase, and HAI-1 in the progression of node-negative breast cancer. Cancer Res 63:1001-1005
4. Kataoka H, Suganuma T, Shimomura T, Itoh H, Kitamura N, Nabeshima K, Koono M (1999) Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J Histochem Cytochem 47:673-682
5. Kim MG, Chen C, Lyu MS, Cho EG, Park D, Kozak C, Schwartz RH (1999) Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains. Immunogenetics 49:420-428
6. Lee S-L, Dickson RB, Lin C-Y (2000) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 275:36720-36725
7. Lin C-Y, Anders J, Johnson M, Dickson RB (1999a) Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 274:18237-18242
8. Lin C-Y, Anders J, Johnson M, Sang QA, Dickson RB (1999b) Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem 274:18231-18236
9. List K, Haudenschild CC, Szabo R, Chen W, Wahl SM, Swaim W, Engelholm LH, et al. (2002) Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21:3765-3779
10. Oberst M, Anders J, Xie B, Singh B, Ossandon M, Johnson M, Dickson RB, Lin C-Y (2001) Matriptase and its cognate inhibitor HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am J Pathol 158:1301-1311
11. Oberst MD, Johnson MD, Dickson RB, Lin C-Y, Singh B, Stewart M, Lessels A, et al. (2002) Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and clinicopathological parameters. Clin Cancer Res 8:1101-1107
12. Satomi S, Yamasaki Y, Tsuzuki S, Hitomi Y, lwanaga T, Fushiki T (2001) A role for membrane-type serine protease (mt-spl) in intestinal epithelial turnover. Biochem Biophys Res Commun 287:995-1002
13. Shimomura T, Denda K, Kitamura A, Kawaguchi T, Kito M, Kondo J, Kagaya S, et al. (1997) Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem 272:6370-6376
14. Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR, Craik CS (2000) Cellular localization of membrane-type serine protease 1 and identification of protease activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 275:26333-26342
15. Takeuchi T, Shuman MA, Craik CS (1999) Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci USA 96:11054-11061
16. Tanimoto H, Underwood LJ, Wang Y, Shigemasa K, Parmley TH, O'Brien TJ (2001) Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention. Tumour Biol 22:104-114